PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
242.97%
Revenue growth exceeding 1.5x CRON.TO's 23.03%. David Dodd would verify if faster growth reflects superior business model.
262.43%
Cost growth less than half of CRON.TO's 640.34%. David Dodd would verify if cost advantage is structural.
191.95%
Positive growth while CRON.TO shows decline. John Neff would investigate competitive advantages.
-14.88%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-63.20%
R&D reduction while CRON.TO shows 10.87% growth. Joel Greenblatt would examine competitive risk.
149.83%
G&A growth above 1.5x CRON.TO's 40.83%. Michael Burry would check for operational inefficiency.
-15.82%
Marketing expense reduction while CRON.TO shows 12.11% growth. Joel Greenblatt would examine competitive risk.
-103.97%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
81.88%
Operating expenses growth above 1.5x CRON.TO's 31.28%. Michael Burry would check for inefficiency.
149.15%
Total costs growth 1.25-1.5x CRON.TO's 116.82%. Martin Whitman would scrutinize control.
15.31%
Interest expense growth while CRON.TO reduces costs. John Neff would investigate differences.
38.60%
D&A growth less than half of CRON.TO's 136.27%. David Dodd would verify if efficiency is sustainable.
-269.53%
EBITDA decline while CRON.TO shows 82.24% growth. Joel Greenblatt would examine position.
-116.66%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-318.21%
Both companies show declining income. Martin Whitman would check industry conditions.
-21.94%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-102.79%
Other expenses reduction while CRON.TO shows 213.32% growth. Joel Greenblatt would examine advantage.
-292.84%
Pre-tax income decline while CRON.TO shows 210.22% growth. Joel Greenblatt would examine position.
-156.23%
Pre-tax margin decline while CRON.TO shows 152.15% growth. Joel Greenblatt would examine position.
-246.51%
Both companies reducing tax expense. Martin Whitman would check patterns.
-299.52%
Net income decline while CRON.TO shows 224.95% growth. Joel Greenblatt would examine position.
-158.17%
Net margin decline while CRON.TO shows 164.13% growth. Joel Greenblatt would examine position.
-295.00%
EPS decline while CRON.TO shows 217.86% growth. Joel Greenblatt would examine position.
-295.00%
Diluted EPS decline while CRON.TO shows 912.50% growth. Joel Greenblatt would examine position.
2.15%
Share count reduction below 50% of CRON.TO's 1.28%. Michael Burry would check for concerns.
0.34%
Diluted share increase while CRON.TO reduces shares. John Neff would investigate differences.